3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
7
Esophageal Squamous Cell Carcinoma
4
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Non-Small-Cell Lung
3
Advanced Solid Tumor
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Advanced Breast Cancer
2
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Solid Tumor
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Papillomavirus Infections
1
Pancreatic Cancer Metastatic
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Muscle Invasive Bladder Cancer (MIBC)
1
Mouth Neoplasms
1
Meningeal Carcinomatosis
1
Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
1
Interventions
Rituximab
2
Radiotherapy, Intensity-Modulated
2
pomalidomide
1
dehydroftorafur
1
Watchful Waiting
1
Vincristine
1
Taxes
1
Prednisone
1
Platinum
1
Phantoms, Imaging
1
Paclitaxel
1
Nivolumab
1
Matrix-M
1
Magnetic Resonance Spectroscopy
1
Gemcitabine
1
Fluorouracil
1
Etoposide
1
Doxorubicin
1
Cyclophosphamide
1
Cisplatin
1
Blood Specimen Collection
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Epstein-Barr Virus Infections
×
toripalimab
×
90 days
×
Clear all
No trials found.